Sawai Group Holdings Co., Ltd. (4887.T)
JPY 2033.5
(-1.09%)
JPY 2033.5
(-1.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 54.31 Billion JPY | -13.27% |
| 2022 | 62.63 Billion JPY | -6.03% |
| 2021 | 66.65 Billion JPY | -7.98% |
| 2020 | 72.43 Billion JPY | -1.45% |
| 2019 | 73.5 Billion JPY | -1.87% |
| 2018 | 74.89 Billion JPY | 14.88% |
| 2017 | 65.19 Billion JPY | 28.03% |
| 2016 | 50.92 Billion JPY | 0.22% |
| 2015 | 50.8 Billion JPY | 11.9% |
| 2014 | 45.4 Billion JPY | 9.49% |
| 2013 | 41.47 Billion JPY | 9.16% |
| 2012 | 37.99 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 14 Billion JPY | 12.54% |
| 2023 FY | 54.31 Billion JPY | -13.27% |
| 2023 Q3 | 14.72 Billion JPY | -13.9% |
| 2023 Q4 | 12.44 Billion JPY | -15.47% |
| 2023 Q1 | 16.15 Billion JPY | 11.65% |
| 2023 Q2 | 17.1 Billion JPY | 5.83% |
| 2022 Q4 | 14.47 Billion JPY | -18.06% |
| 2022 Q3 | 17.66 Billion JPY | 16.79% |
| 2022 Q2 | 15.12 Billion JPY | -1.66% |
| 2022 Q1 | 15.37 Billion JPY | 26.48% |
| 2022 FY | 62.63 Billion JPY | -6.03% |
| 2021 Q4 | 12.15 Billion JPY | -34.66% |
| 2021 Q1 | 18.7 Billion JPY | 19.58% |
| 2021 FY | 66.65 Billion JPY | -7.98% |
| 2021 Q3 | 18.6 Billion JPY | 8.31% |
| 2021 Q2 | 17.17 Billion JPY | -8.18% |
| 2020 Q3 | 20.71 Billion JPY | 12.32% |
| 2020 Q1 | 17.62 Billion JPY | 7.65% |
| 2020 FY | 72.43 Billion JPY | -1.45% |
| 2020 Q4 | 15.64 Billion JPY | -24.48% |
| 2020 Q2 | 18.44 Billion JPY | 4.66% |
| 2019 Q4 | 16.37 Billion JPY | -17.76% |
| 2019 Q3 | 19.9 Billion JPY | 14.94% |
| 2019 Q2 | 17.31 Billion JPY | -12.98% |
| 2019 FY | 73.5 Billion JPY | -1.87% |
| 2019 Q1 | 19.9 Billion JPY | 2.88% |
| 2018 Q2 | 18.02 Billion JPY | -2.05% |
| 2018 Q3 | 19.12 Billion JPY | 6.07% |
| 2018 Q1 | 18.4 Billion JPY | -8.27% |
| 2018 FY | 74.89 Billion JPY | 14.88% |
| 2018 Q4 | 19.34 Billion JPY | 1.17% |
| 2017 FY | 65.19 Billion JPY | 28.03% |
| 2017 Q1 | 13.76 Billion JPY | 17.95% |
| 2017 Q4 | 20.06 Billion JPY | -0.64% |
| 2017 Q3 | 20.19 Billion JPY | 30.98% |
| 2017 Q2 | 15.41 Billion JPY | 12.03% |
| 2016 Q2 | 12.99 Billion JPY | -4.65% |
| 2016 Q4 | 11.66 Billion JPY | -15.63% |
| 2016 Q1 | 13.62 Billion JPY | 15.04% |
| 2016 Q3 | 13.83 Billion JPY | 6.43% |
| 2016 FY | 50.92 Billion JPY | 0.22% |
| 2015 FY | 50.8 Billion JPY | 11.9% |
| 2015 Q4 | 11.84 Billion JPY | -19.2% |
| 2015 Q3 | 14.66 Billion JPY | 18.9% |
| 2015 Q2 | 12.33 Billion JPY | -3.63% |
| 2015 Q1 | 12.79 Billion JPY | 24.0% |
| 2014 Q4 | 10.31 Billion JPY | -21.08% |
| 2014 Q3 | 13.07 Billion JPY | 19.51% |
| 2014 Q2 | 10.94 Billion JPY | -1.17% |
| 2014 Q1 | 11.07 Billion JPY | 26.87% |
| 2014 FY | 45.4 Billion JPY | 9.49% |
| 2013 Q2 | 9.64 Billion JPY | -11.07% |
| 2013 Q1 | 10.84 Billion JPY | 22.49% |
| 2013 Q4 | 8.72 Billion JPY | -28.83% |
| 2013 FY | 41.47 Billion JPY | 9.16% |
| 2013 Q3 | 12.26 Billion JPY | 27.16% |
| 2012 Q4 | 8.85 Billion JPY | -20.03% |
| 2012 Q2 | 9.05 Billion JPY | 0.0% |
| 2012 FY | 37.99 Billion JPY | 0.0% |
| 2012 Q3 | 11.06 Billion JPY | 22.18% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -11.419% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 97.514% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 71.104% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 85.283% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -1434.068% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 44.011% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -42.114% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 90.737% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -805.619% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 31.217% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -4.319% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -301.857% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -601.977% |
| Tsumura & Co. | 68.81 Billion JPY | 21.067% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -45.467% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -119.099% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 33.255% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -228.907% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -8.245% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -5.679% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -4934.198% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -452.078% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1131.44% |
| MedRx Co., Ltd | 26 Million JPY | -208819.231% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -576.812% |
| Solasia Pharma K.K. | 337 Million JPY | -16018.398% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 7430879.754% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -77.137% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -143814.265% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 51.924% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -718.106% |